Reuters logo
7 months ago
BRIEF-PTC Therapeutics announces initiation of firefish study in infant SMA patients
January 5, 2017 / 1:25 PM / 7 months ago

BRIEF-PTC Therapeutics announces initiation of firefish study in infant SMA patients

1 Min Read

Jan 5 (Reuters) - Ptc Therapeutics Inc

* PTC Therapeutics announces initiation of firefish study in infant (type I) SMA patients

* Joint development program in spinal muscular atrophy with roche, SMA foundation initiated clinical study in infants with type I SMA

* Clinical study will investigate safety, tolerability and efficacy of RG7916 in babies aged 1 to 7 months Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below